Meridian Bioscience, Inc. (VIVO) Tops Q4 EPS by 2c

Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q4 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.7 million versus the consensus estimate of $42.97 million.

For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)